milwaukee glp-1 Weight Loss Clinic GLP-1 Medications in Milwaukee: What
Description
2023;24:e13543
Br J Anaesth 2021
From 2019 to 2024, among all adult patients with an overweight or obesity diagnosis, the percentage who were prescribed a GLP-1 drug but did not have bariatric surgery increased from 2.5 percent in 2019 to 11.2 percent in 2024, a relative increase of 339.5 percent
Given these differences in cohort characteristics, and that women appeared to experience greater WL than men with retatrutide, it may suggest that the mean WL might have been even higher with a higher proportion of women in phase 2 retatrutide trials
The key is timing, strategy, and individualized care
p38 MAPK: p38 mitogen-activated protein kinase
